vs
Tonix Pharmaceuticals Holding Corp.（TNXP）与TECHPRECISION CORP（TPCS）财务数据对比。点击上方公司名可切换其他公司
TECHPRECISION CORP的季度营收约是Tonix Pharmaceuticals Holding Corp.的1.3倍（$7.1M vs $5.4M），TECHPRECISION CORP净利率更高（-20.8% vs -870.3%，领先849.6%），Tonix Pharmaceuticals Holding Corp.同比增速更快（108.8% vs -6.9%），TECHPRECISION CORP自由现金流更多（$-827.0K vs $-41.5M），过去两年Tonix Pharmaceuticals Holding Corp.的营收复合增速更高（47.4% vs -9.2%）
Tonix Pharmaceuticals是一家总部位于美国新泽西州查塔姆的制药企业，核心业务聚焦于中枢神经系统疾病适应症的再利用药物开发，截至2020年，该公司同时还在开展新冠疫苗研发以及一个生物防御相关项目。
TechPrecision Corp是一家专业生产定制高精度金属部件与集成系统的制造商，服务航空航天、国防、医疗科技、可再生能源等核心领域，为欧美客户提供符合严苛行业标准的关键任务零部件。
TNXP vs TPCS — 直观对比
营收规模更大
TPCS
是对方的1.3倍
$5.4M
营收增速更快
TNXP
高出115.7%
-6.9%
净利率更高
TPCS
高出849.6%
-870.3%
自由现金流更多
TPCS
多$40.7M
$-41.5M
两年增速更快
TNXP
近两年复合增速
-9.2%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.4M | $7.1M |
| 净利润 | $-46.9M | $-1.5M |
| 毛利率 | 80.4% | 5.4% |
| 营业利润率 | -895.8% | -19.1% |
| 净利率 | -870.3% | -20.8% |
| 营收同比 | 108.8% | -6.9% |
| 净利润同比 | -112.2% | -84.4% |
| 每股收益（稀释后） | $-4.28 | $-0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TNXPTPCS
| Q4 25 | $5.4M | $7.1M | ||
| Q3 25 | $3.3M | $9.1M | ||
| Q2 25 | $2.0M | $7.4M | ||
| Q1 25 | $2.4M | $9.5M | ||
| Q4 24 | $2.6M | $7.6M | ||
| Q3 24 | $2.8M | $8.9M | ||
| Q2 24 | $2.2M | $8.0M | ||
| Q1 24 | $2.5M | $8.6M |
净利润TNXPTPCS
| Q4 25 | $-46.9M | $-1.5M | ||
| Q3 25 | $-32.0M | $825.0K | ||
| Q2 25 | $-28.3M | $-597.0K | ||
| Q1 25 | $-16.8M | $112.0K | ||
| Q4 24 | $-22.1M | $-799.0K | ||
| Q3 24 | $-14.2M | $-601.0K | ||
| Q2 24 | $-78.8M | $-1.5M | ||
| Q1 24 | $-14.9M | $-5.1M |
毛利率TNXPTPCS
| Q4 25 | 80.4% | 5.4% | ||
| Q3 25 | 58.4% | 27.1% | ||
| Q2 25 | -63.8% | 14.0% | ||
| Q1 25 | 61.2% | 22.0% | ||
| Q4 24 | 54.2% | 13.0% | ||
| Q3 24 | 44.9% | 11.3% | ||
| Q2 24 | -52.5% | 3.0% | ||
| Q1 24 | 33.1% | 14.3% |
营业利润率TNXPTPCS
| Q4 25 | -895.8% | -19.1% | ||
| Q3 25 | -1005.1% | 10.4% | ||
| Q2 25 | -1416.2% | -6.3% | ||
| Q1 25 | -660.9% | 3.9% | ||
| Q4 24 | -870.6% | -9.1% | ||
| Q3 24 | -551.2% | -5.5% | ||
| Q2 24 | -3501.6% | -16.8% | ||
| Q1 24 | -860.2% | -28.6% |
净利率TNXPTPCS
| Q4 25 | -870.3% | -20.8% | ||
| Q3 25 | -972.9% | 9.1% | ||
| Q2 25 | -1415.0% | -8.1% | ||
| Q1 25 | -692.8% | 1.2% | ||
| Q4 24 | -856.2% | -10.5% | ||
| Q3 24 | -503.6% | -6.7% | ||
| Q2 24 | -3567.8% | -18.3% | ||
| Q1 24 | -601.9% | -59.5% |
每股收益（稀释后）TNXPTPCS
| Q4 25 | $-4.28 | $-0.15 | ||
| Q3 25 | $-3.59 | $0.08 | ||
| Q2 25 | $-3.86 | $-0.06 | ||
| Q1 25 | $-2.84 | $0.01 | ||
| Q4 24 | $2302.65 | $-0.08 | ||
| Q3 24 | $-22.68 | $-0.06 | ||
| Q2 24 | $-1920.85 | $-0.16 | ||
| Q1 24 | $-535.72 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $207.6M | $50.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.2M | $8.0M |
| 总资产 | $277.2M | $32.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资TNXPTPCS
| Q4 25 | $207.6M | $50.0K | ||
| Q3 25 | $190.1M | $220.0K | ||
| Q2 25 | $125.3M | $143.0K | ||
| Q1 25 | $131.7M | $195.0K | ||
| Q4 24 | $98.8M | $165.0K | ||
| Q3 24 | $28.2M | $132.0K | ||
| Q2 24 | $4.2M | $44.8K | ||
| Q1 24 | $7.0M | $138.0K |
总债务TNXPTPCS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | $8.7M | $19.0K | ||
| Q3 24 | $9.4M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $10.8M | — |
股东权益TNXPTPCS
| Q4 25 | $245.2M | $8.0M | ||
| Q3 25 | $231.1M | $9.1M | ||
| Q2 25 | $168.0M | $8.2M | ||
| Q1 25 | $180.4M | $8.7M | ||
| Q4 24 | $139.6M | $8.1M | ||
| Q3 24 | $74.2M | $8.9M | ||
| Q2 24 | $42.1M | $7.9M | ||
| Q1 24 | $108.1M | $7.8M |
总资产TNXPTPCS
| Q4 25 | $277.2M | $32.8M | ||
| Q3 25 | $252.4M | $33.8M | ||
| Q2 25 | $187.4M | $32.1M | ||
| Q1 25 | $192.9M | $33.5M | ||
| Q4 24 | $162.9M | $32.2M | ||
| Q3 24 | $95.0M | $35.0M | ||
| Q2 24 | $70.3M | $35.7M | ||
| Q1 24 | $135.3M | $34.7M |
负债/权益比TNXPTPCS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | 0.06× | 0.00× | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.6M | $183.0K |
| 自由现金流经营现金流 - 资本支出 | $-41.5M | $-827.0K |
| 自由现金流率自由现金流/营收 | -770.4% | -11.7% |
| 资本支出强度资本支出/营收 | 34.8% | 14.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-103.2M | $-4.4M |
8季度趋势，按日历期对齐
经营现金流TNXPTPCS
| Q4 25 | $-39.6M | $183.0K | ||
| Q3 25 | $-28.8M | $-1.1M | ||
| Q2 25 | $-14.8M | $646.0K | ||
| Q1 25 | $-16.6M | $396.0K | ||
| Q4 24 | $-14.6M | $-570.0K | ||
| Q3 24 | $-18.8M | $-532.0K | ||
| Q2 24 | $-9.9M | $107.0K | ||
| Q1 24 | $-17.6M | $-452.0K |
自由现金流TNXPTPCS
| Q4 25 | $-41.5M | $-827.0K | ||
| Q3 25 | $-29.7M | $-2.1M | ||
| Q2 25 | $-15.4M | $-604.0K | ||
| Q1 25 | $-16.6M | $-930.0K | ||
| Q4 24 | $-14.6M | $-1.7M | ||
| Q3 24 | $-18.8M | $-2.0M | ||
| Q2 24 | — | $-94.0K | ||
| Q1 24 | $-17.7M | $-900.0K |
自由现金流率TNXPTPCS
| Q4 25 | -770.4% | -11.7% | ||
| Q3 25 | -904.1% | -22.9% | ||
| Q2 25 | -768.8% | -8.2% | ||
| Q1 25 | -682.8% | -9.8% | ||
| Q4 24 | -566.7% | -22.9% | ||
| Q3 24 | -666.5% | -21.8% | ||
| Q2 24 | — | -1.2% | ||
| Q1 24 | -712.4% | -10.5% |
资本支出强度TNXPTPCS
| Q4 25 | 34.8% | 14.2% | ||
| Q3 25 | 29.2% | 11.0% | ||
| Q2 25 | 26.4% | 16.9% | ||
| Q1 25 | 0.2% | 14.0% | ||
| Q4 24 | 0.1% | 15.4% | ||
| Q3 24 | 0.3% | 15.9% | ||
| Q2 24 | 0.0% | 2.5% | ||
| Q1 24 | 4.4% | 5.2% |
现金转化率TNXPTPCS
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TNXP
| Zembrace Symtouch | $3.1M | 58% |
| Other | $2.3M | 42% |
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
